Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic variation in alpha2A adrenergic receptor and cardiovascular effects of dexmedetomidine
ChiCTR-OPC-16008350Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine, sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Blood pressure and Heart rate. Planned start Jun 2016; status: not yet recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ChiCTR-OPC-16008350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008350.